Boston Partners Has $7.88 Million Position in Envision Healthcare Corporation (EVHC)

Boston Partners boosted its position in shares of Envision Healthcare Corporation (NYSE:EVHC) by 59.8% during the second quarter, Holdings Channel reports. The fund owned 125,697 shares of the company’s stock after buying an additional 47,038 shares during the period. Boston Partners’ holdings in Envision Healthcare Corporation were worth $7,877,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Osborne Partners Capital Management LLC increased its position in Envision Healthcare Corporation by 0.5% in the first quarter. Osborne Partners Capital Management LLC now owns 55,985 shares of the company’s stock worth $3,433,000 after buying an additional 297 shares during the period. Mn Services Vermogensbeheer B.V. bought a new position in Envision Healthcare Corporation during the first quarter worth approximately $495,000. Nationwide Fund Advisors increased its position in Envision Healthcare Corporation by 133.1% in the first quarter. Nationwide Fund Advisors now owns 553,881 shares of the company’s stock worth $33,964,000 after buying an additional 316,228 shares during the period. Candriam Luxembourg S.C.A. bought a new position in Envision Healthcare Corporation during the first quarter worth approximately $3,100,000. Finally, Douglas Lane & Associates LLC increased its position in Envision Healthcare Corporation by 916.8% in the first quarter. Douglas Lane & Associates LLC now owns 34,702 shares of the company’s stock worth $2,128,000 after buying an additional 31,289 shares during the period. Institutional investors and hedge funds own 64.75% of the company’s stock.

Envision Healthcare Corporation (EVHC) opened at 49.88 on Friday. The stock’s market capitalization is $5.84 billion. The firm’s 50-day moving average is $58.00 and its 200 day moving average is $60.59. Envision Healthcare Corporation has a 12 month low of $49.82 and a 12 month high of $74.75.

Envision Healthcare Corporation (NYSE:EVHC) last released its quarterly earnings results on Monday, August 7th. The company reported $0.79 EPS for the quarter, topping the consensus estimate of $0.75 by $0.04. The business had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.96 billion. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. The company’s quarterly revenue was up 156.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.34 earnings per share. On average, equities analysts anticipate that Envision Healthcare Corporation will post $1.40 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://sportsperspectives.com/2017/08/18/boston-partners-has-7-88-million-position-in-envision-healthcare-corporation-evhc.html.

EVHC has been the topic of a number of recent analyst reports. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $80.00 target price on shares of Envision Healthcare Corporation in a research report on Tuesday, July 4th. Zacks Investment Research raised shares of Envision Healthcare Corporation from a “strong sell” rating to a “buy” rating and set a $70.00 target price on the stock in a research report on Tuesday, July 4th. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $72.00 target price on shares of Envision Healthcare Corporation in a research report on Monday, June 5th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $71.00 target price (down from $75.00) on shares of Envision Healthcare Corporation in a research report on Wednesday, May 3rd. Finally, Mizuho dropped their target price on shares of Envision Healthcare Corporation from $70.00 to $60.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 30th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $71.56.

In other news, insider Robert Jon Coward sold 1,500 shares of the company’s stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $62.69, for a total transaction of $94,035.00. Following the completion of the transaction, the insider now owns 97,863 shares in the company, valued at $6,135,031.47. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.10% of the stock is currently owned by corporate insiders.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Corporation (NYSE:EVHC).

Institutional Ownership by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply